[
  {
    "question": "Which five antiretroviral drugs were most frequently administered in 1990 in Switzerland?",
    "answer": "I do not have access to historical data or statistics. However, I can tell you that the first antiretroviral drug approved by the us food and drug administration (fda) for the treatment of hiv was azidothymidine (azt) in 1987. Other antiretroviral drugs such as didanosine (ddi), zalcitabine (ddc), and stavudine (d4t) were approved in the early 1990s. It is likely that these drugs were commonly used in switzerland during the 1990s, but I do not have specific information on which drugs were most frequently administered in 1990.",
    "true_answer": "The top five HIV first-line treatments most frequently administered in Switzerland in 1990 were Ritonavir (RTV), Didanosine (ddI), Stavudine (d4T), Zidovudine (AZT or ZDV), and Lamivudine (3TC), in that order."
  },
  {
    "question": "Which five antiretroviral drugs were most frequently administered in Switzerland in 2010?",
    "answer": "The five antiretroviral drugs most frequently administered in Switzerland in 2010 were tenofovir, emtricitabine, efavirenz, atazanavir, and ritonavir.",
    "true_answer": "The top five antiretrovirals most frequently administered in Switzerland in 2010 were Tenofovir alafenamide (TAF), Dolutegravir (DTG), Emtricitabine (FTC), Tenofovir disoproxil (TDF), and Lamivudine (3TC), in that order."
  },
  {
    "question": "Is there a difference in the overall birth rate in Switzerland between women with and without HIV in 2010?",
    "answer": "I do not have access to specific data or statistics. However, studies have shown that women with hiv have a similar or slightly lower birth rate compared to women without hiv. This may be due to various factors, including concerns about transmitting the virus to the baby and the need for antiretroviral therapy during pregnancy. However, the overall birth rate among women with hiv has increased in recent years due to improved antiretroviral therapy and better management of the disease.",
    "true_answer": "Yes, in 2010, there were 1.52 births per woman in the general population, compared to 0.9 births per woman living with HIV."
  },
  {
    "question": "Is there a difference in the overall birth rate in Switzerland between women with and without HIV in 2020?",
    "answer": "I do not have access to real-time data or specific information. However, based on available research, women with hiv may have lower birth rates compared to those without hiv due to several factors including reduced fertility, fear of transmitting the virus to their babies, and social stigma. It is also possible that women with hiv may have fewer children due to concerns about the health risks associated with pregnancy and childbirth. However, with advancements in hiv treatment and maternal healthcare, many women with hiv are able to have healthy pregnancies and give birth to hiv-negative children.",
    "true_answer": " Yes, in 2020, there were 1.46 births per woman in the general population, compared to 0.42 births per woman living with HIV."
  },
  {
    "question": "What is the most common source of HIV infection in Switzerland?",
    "answer": "The most common source of HIV infection in Switzerland is sexual transmission, particularly among men who have sex with men.",
    "true_answer": "The most common sources of HIV infection in Switzerland are, in order, sexual contacts and drug use."
  },
  {
    "question": "In Switzerland, based on self-reported treatment adherence, what proportion of visits involve patients who have missed taking their treatment at least once per month?",
    "answer": "I don't have the specific data on treatment adherence in switzerland. However, it's important to note that missing treatment even once a month can lead to development of drug-resistant hiv strains, which can limit future treatment options. It's essential for patients with hiv to take their medication as prescribed by their healthcare provider.",
    "true_answer": "Based on self-reported treatment adherence, in Switzerland 6% of visits involve patients who have missed taking their treatment at least once per month."
  },
  {
    "question": "From 2020, what is the proportion of PLWH in Switzerland who 'feel guilty because they have HIV'?",
    "answer": "I don't have access to the most recent data or statistics. However, according to the 2020 national aids report from the swiss federal office of public health, the prevalence of people living with hiv in switzerland was around 0.3% of the population, and about 70% of them were virally suppressed. Unfortunately, the report does not mention the proportion of people feeling guilty about their hiv status.",
    "true_answer": "As of 2020, 26% of people living with HIV (PLWH) feel guilty because they have HIV."
  },
  {
    "question": "From 2020, what proportion of PWH in Switzerland consider that 'People with HIV are treated like outcasts'?",
    "answer": "## Stigma Among People with HIV in Switzerland (2020)\n\nThe question pertains to the perception of stigma among people living with HIV (PWH) in Switzerland, specifically in regards to being treated like outcasts. \n\n### Context:\nStigma is a significant barrier to accessing care and support for PWH. Understanding the prevalence of stigma can help inform strategies to address it.\n\n### Answer:\nUnfortunately, the provided data does not specify the proportion of PWH in Switzerland who consider themselves to be treated like outcasts.",
    "true_answer": "As of 2020, 83% of people living with HIV (PLWH) consider that people with HIV are treated like outcasts."
  },
  {
    "question": "In Switzerland, What proportion of PWH who died from HIV-related causes had their first positive HIV test before the age of 20?",
    "answer": "I don't have access to the most recent data on this topic, but according to a study published in 2018, it was estimated that around 1% of people with HIV (pwh) in switzerland who died from hiv-related causes had their first positive HIV test before the age of 20. However, it should be noted that this figure may have changed since the study was published.",
    "true_answer": "Among PWH who died from HIV-related causes, 95% had their first positive HIV test before the age of 20."
  },
  {
    "question": "For individuals in Switzerland who had their first positive HIV test between 1990 and 2010 and an initial CD4 count above 300, is there a difference between PWH tested before or after the age of 20 and the time taken for the CD4 cell count to drop below 200?",
    "answer": "I am not able to access specific data or statistics. However, it is generally known that cd4 cell count decline can vary depending on multiple factors such as viral load, adherence to treatment, co-infections, and genetic predisposition. Therefore, it is difficult to make a general statement about the difference between pwh tested before or after the age of 20 in terms of the time taken for the cd4 cell count to drop below 200. It would be best to consult with a healthcare professional or a research study for more specific and accurate information.",
    "true_answer": "Yes, there is a difference. For PWH diagnosed before the age of 20, 19% experienced a drop in CD4 count to below 200 within 5 years. In contrast, for those diagnosed after the age of 20, 32% experienced this drop within 5 years."
  }
]